Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 151-160 of 162 for obesity

Edit search filters
  1. Humans With Obesity Response to Exercise

    Rochester, MN

  2. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers

    Rochester, MN

  3. A Study of the Influence of Central Obesity on the Esophageal Epithelial Barrier

    Rochester, MN

  4. A Study to See if There is a Connection Between Bad Childhood Experiences and Poor Blood Sugar Control in Patients with Type 1 Diabetes

    Rochester, MN

  5. A Study Of Obesity Phenotypes After PCI And CABG

    Rochester, MN

  6. A Study to Evaluate Magnetic Resonance (MR) to Estimate Liver Fat and Fibrosis Among American Indians with High Rates of Obesity, Insulin Resistance, and Variable Alcohol Use

    Scottsdale/Phoenix, AZ

  7. Dynamic Multiparametric Gastric MRI in Endoscopic Sleeve Gastroplasty for the Primary Treatment of Obesity

    Scottsdale/Phoenix, AZ

  8. A Study Of Obesity Phenotypes To Improve Outcomes After Transcatheter Aortic, Mitral, And Tricuspid Valve Interventions

    Rochester, MN

  9. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications.

    Scottsdale/Phoenix, AZ

  10. A Study to Develop a Novel Methodology to Quantify Hepatic Fat Content in Humans

    Rochester, MN

.

Mayo Clinic Footer